Pictet Asset Management (UK)’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $2.19M | Sell |
158,575
-20,863
| -12% | -$289K | ﹤0.01% | 985 |
|
|
2021
Q1 | $2.62M | Buy |
179,438
+4,740
| +3% | +$69.3K | ﹤0.01% | 942 |
|
|
2020
Q4 | $3.04M | Sell |
174,698
-11,300
| -6% | -$196K | ﹤0.01% | 904 |
|
|
2020
Q3 | $3.41M | Sell |
185,998
-4,300
| -2% | -$78.9K | 0.01% | 805 |
|
|
2020
Q2 | $3.4M | Sell |
190,298
-16,900
| -8% | -$302K | 0.01% | 778 |
|
|
2020
Q1 | $3.36M | Buy |
207,198
+94,900
| +85% | +$1.54M | 0.01% | 737 |
|
|
2019
Q4 | $2.02M | Buy |
+112,298
| New | +$2.02M | ﹤0.01% | 913 |
|
|
2018
Q2 | – | Sell |
-66,906
| Closed | -$739K | – | 888 |
|
|
2018
Q1 | $739K | Hold |
66,906
| – | – | ﹤0.01% | 837 |
|
|
2017
Q4 | $589K | Buy |
66,906
+3,773
| +6% | +$33.2K | ﹤0.01% | 845 |
|
|
2017
Q3 | $843K | Buy |
63,133
+37,942
| +151% | +$507K | ﹤0.01% | 838 |
|
|
2017
Q2 | $498K | Sell |
25,191
-416,597
| -94% | -$8.24M | ﹤0.01% | 843 |
|
|
2017
Q1 | $9.34M | Buy |
441,788
+1,432
| +0.3% | +$30.3K | 0.03% | 483 |
|
|
2016
Q4 | $12.4M | Buy |
440,356
+60,264
| +16% | +$1.7M | 0.05% | 404 |
|
|
2016
Q3 | $10.2M | Buy |
+380,092
| New | +$10.2M | 0.04% | 426 |
|